• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,164
2,283
1,859
1,828
1,712

COUNTRY

877
643
263
249
208

CATEGORIES

  • 856
  • 184
  • 950
  • 1,127
    • 99
  • 385
  • 271
  • 251
  • 65
  • 379
  • 673
  • 1,258
  • 1,621
  • 625
  • 883
  • 1,673
  • 2,638
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 727
  • 0
  • 97

PRICE

6,739
11,286
16,980
24,682

PUBLISHED

1,615
2,882
7,009
24,682

PRODUCT TYPE

20,309
3,174
856
164
74
44
21
21
12
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Angiogenesis Triple Analysis: Breast Cancer, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Melanoma and Angiogenesis Triple Analysis: Colorectal Cancer, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual...

June 2013
FROM
Triple Analysis: Leukemia, Lung Cancer and Melanoma Triple Analysis: Leukemia, Lung Cancer and Melanoma - Product Thumbnail Image

Triple Analysis: Leukemia, Lung Cancer and Melanoma

This triple analysis focuses on cancer drug development strategies in Leukemia, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five...

June 2013
FROM
Triple Analysis: Leukemia, Melanoma and Protein Kinase Inhibitors Triple Analysis: Leukemia, Melanoma and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Leukemia, Melanoma and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts...

June 2013
FROM
Triple Analysis: Leukemia, Melanoma and Peptides Triple Analysis: Leukemia, Melanoma and Peptides - Product Thumbnail Image

Triple Analysis: Leukemia, Melanoma and Peptides

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according...

June 2013
FROM
Triple Analysis: Lung Cancer, Melanoma and Angiogenesis Triple Analysis: Lung Cancer, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Lung Cancer, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts...

June 2013
FROM
Triple Analysis: Lymphoma, Melanoma and Prostate Cancer Triple Analysis: Lymphoma, Melanoma and Prostate Cancer - Product Thumbnail Image

Triple Analysis: Lymphoma, Melanoma and Prostate Cancer

This triple analysis focuses on cancer drug development strategies in Lymphoma, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in...

June 2013
FROM
Triple Analysis: Lymphoma, Melanoma and Angiogenesis Triple Analysis: Lymphoma, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Lymphoma, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual...

June 2013
FROM
Triple Analysis: Melanoma, Cancer Vaccines and Peptides Triple Analysis: Melanoma, Cancer Vaccines and Peptides - Product Thumbnail Image

Triple Analysis: Melanoma, Cancer Vaccines and Peptides

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides)....

June 2013
FROM
Triple Analysis: Breast Cancer, Leukemia and Melanoma Triple Analysis: Breast Cancer, Leukemia and Melanoma - Product Thumbnail Image

Triple Analysis: Breast Cancer, Leukemia and Melanoma

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Leukemia and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a...

June 2013
FROM
Triple Analysis: Breast Cancer, Lymphoma and Melanoma Triple Analysis: Breast Cancer, Lymphoma and Melanoma - Product Thumbnail Image

Triple Analysis: Breast Cancer, Lymphoma and Melanoma

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lymphoma and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Antibodies Triple Analysis: Breast Cancer, Melanoma and Antibodies - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Antibodies

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Lymphoma and Melanoma Triple Analysis: Colorectal Cancer, Lymphoma and Melanoma - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Lymphoma and Melanoma

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lymphoma and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Melanoma and Antibodies Triple Analysis: Colorectal Cancer, Melanoma and Antibodies - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Melanoma and Antibodies

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Leukemia, Melanoma and Apoptosis Triple Analysis: Leukemia, Melanoma and Apoptosis - Product Thumbnail Image

Triple Analysis: Leukemia, Melanoma and Apoptosis

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according...

June 2013
FROM
Triple Analysis: Leukemia, Melanoma and Cancer Vaccines Triple Analysis: Leukemia, Melanoma and Cancer Vaccines - Product Thumbnail Image

Triple Analysis: Leukemia, Melanoma and Cancer Vaccines

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated...

June 2013
FROM
Loading Indicator

Our Clients

Our clients' logos